Unknown

Dataset Information

Pembrolizumab KEYNOTE-001: an adaptive study leading to accelerated approval for two indications and a companion diagnostic.


ABSTRACT:

SUBMITTER: Kang SP 

PROVIDER: S-EPMC5452070 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature